Kura Oncology reports early activity for darlifarnib–cabozantinib combination in cabozantinib‑pretreated ccRCC

Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic

Bold Therapeutics reports protection against chemotherapy-induced peripheral neuropathy with BOLD-100 anticancer agent

Philips secures FDA clearance for Spectral CT Verida system

Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology

Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential

Asgard Therapeutics appoints chief medical officer

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting

Senhwa Biosciences secures up to TWD500m funding for AI-driven drug development

CrossBridge Bio to be acquired by Eli Lilly

IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination

Kazia Therapeutics in-licenses SETDB1 inhibitor drug development platform

Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO

Genmab reports positive safety data for Rina-S combination in ovarian cancer

GSK reports strong early-stage data for B7-H4 ADC in gynaecological cancers